COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN
- Authors: Tatochenko V.K.1, Tatochenko VK1
-
Affiliations:
- Issue: No 1 (2012)
- Pages: 58-63
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279180
- ID: 279180
Cite item
Full Text
Abstract
The article describes the approaches to the diagnosis of community-acquired pneumonia in children; Russian diagnostic criteria with high sensitivity and specificity for bacterial etiology of pneumonia are provided. Although etiological structure of pneumonia varies at different ages, leading pathogens are pneumococci; in children under 5 years - Haemophilus influenzae, in adolescents - atypical pathogens: mycoplasma and chlamydia. Against the background of pneumococcal resistance to many antibiotics, the main drug of first choice is amoxycillin in a dosage of 50 mg/kg/day in 2 divided doses (up to 5 years - amoxicillin/clavulanate at the same dose), and for those with suspected resistance flora (children from boarding schools and preschool institutions, as well as contacting with them) - doubling the dose of these drugs. The ineffectiveness of β-lactams provides evidence of probable atypical pneumonia, which requires administration of macrolides.
References
- Домбровская Ю.Ф. и др. Проект классификации клинических форм бронхолегочных заболеваний неспецифической этиологии у детей // Педиатрия 1973. № 9. С. 3-7.
- Таточенко В.К. Острые пневмонии у детей. Чебоксары, 1994. 323 с.
- Bradley JS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis 2011;53(7): 617-30.
- US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry. Community-acquired bacterial pneumonia: developing drugs for treatment. 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm123686.pdf.
- World Health Organization Pneumonia Vaccine Trial Investigators' Group. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. WHO, Geneva 2001.
- Козлов Р.С., Сивая О.В., Кречикова О.И. и др. Динамика резистентности Streptococcus pneumoniae к антибиотикам в России за период 1999-2009 гг. (Результаты многоцентрового проспективного исследования ПеГАС) // Клин. микробиол. антимикроб. химиотер. 2010. Т. 12. № 4. С. 1-13.
- Сидоренко С.В., Грудинина С.А., Филимонова О.Ю. и др. Резистентность к макролидам и линкозамидам среди Streptococcus pneumoniae и Streptococcus pyogenes в Российской Федерации // Клин. фармакол. тер. 2008. Т. 17. №. 2. С. 1-4.
- Клинические рекомендации. Педиатрия 2005-2006 / Под ред А.А Баранова. 2-е изд. М., 2009. 432 с.
- Руководство по амбулаторно-клинической педиатрии / Под ред А.А Баранова. 2-е изд. М., 2009. 582 с.
- Российский национальный Педиатрический формуляр / Под ред. А.А. Баранова. М., 2009. 908 с.
- Баранов А.А., Таточенко В.К., Бакрадзе М.Д. Лихорадочные состояния у детей. Рекомендации по диагностике и лечению. М., 2011. 210 с.
- Таточенко В.К. Противомикробная терапия. Справочник педиатра. М., 2010. 158 с.
Supplementary files
